How long should prednisolone be given and tapered in an infant with MIS‑C or severe acute COVID‑19?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Duration and Tapering of Prednisolone in MIS-C

For infants with MIS-C, prednisolone should be given at 1-2 mg/kg/day initially and tapered over 2-3 weeks total duration, transitioning from IV to oral as clinical improvement occurs, with the taper guided by resolution of fever, normalization of inflammatory markers (CRP, ESR), and cardiac function stabilization.

Initial Treatment Phase

The American College of Rheumatology 2021 guidelines establish methylprednisolone (or equivalent prednisolone dosing) at 1-2 mg/kg/day as first-line therapy in combination with IVIG for MIS-C 1. This represents the standard initial approach for moderate disease without shock or organ-threatening complications.

For infants with more severe presentations requiring intensification, methylprednisolone can be escalated to 10-30 mg/kg/day if there is persistent fever or ongoing significant end-organ involvement despite initial therapy 1.

Treatment Duration and Tapering Strategy

While the ACR guidelines provide dosing recommendations, they do not specify exact duration or taper schedules 1. However, based on clinical practice patterns and the evidence base:

Acute Phase (Days 1-5)

  • Continue full-dose steroids (1-2 mg/kg/day) until fever resolves for at least 24-48 hours
  • Monitor inflammatory markers (CRP, ESR) and cardiac function daily
  • Transition from IV to oral prednisolone once clinically stable and tolerating oral intake

Taper Phase (Days 6-21)

  • Begin gradual taper once fever has resolved and inflammatory markers are trending down
  • Reduce dose by approximately 25-33% every 3-5 days
  • Monitor for rebound inflammation during taper (recurrent fever, rising CRP)
  • Total steroid course typically 2-3 weeks to prevent rebound hyperinflammation

Key Monitoring Parameters During Taper

Clinical indicators for successful taper:

  • Sustained afebrile state (>48 hours)
  • CRP declining to <60 mg/L by day 3 (associated with better outcomes) 2
  • Normalization of cardiac function and BNP levels
  • Resolution of gastrointestinal symptoms
  • Stable or improving coronary artery dimensions on echocardiography

Evidence Supporting Early Initiation

Research demonstrates that initiating steroids within 24 hours of admission reduces hospital length of stay by approximately 58 hours compared to delayed initiation 3. This supports aggressive early treatment rather than a wait-and-see approach.

Common Pitfalls to Avoid

Premature discontinuation: Abruptly stopping steroids or tapering too rapidly (over <2 weeks) risks rebound inflammation and disease recurrence. The FDA label specifically warns against abrupt withdrawal after long-term therapy 4.

Inadequate initial dosing: Using doses below 1 mg/kg/day may be insufficient for the hyperinflammatory state in MIS-C. The ACR guidelines specifically recommend 1-2 mg/kg/day as the minimum effective dose 1.

Ignoring cardiac dysfunction: Infants with significant cardiac involvement may require longer courses or slower tapers. Coronary abnormalities persisted in 34-48% of patients at 2 weeks in some cohorts 2, necessitating extended monitoring.

Alternative Scenarios

For refractory disease: If fever persists beyond 36 hours despite initial therapy, escalate to high-dose methylprednisolone (10-30 mg/kg/day) or consider adding anakinra 1, 2.

Resource-limited settings: When IVIG is unavailable, high-dose prednisolone (4 mg/kg/day for 4 days) has shown favorable outcomes as monotherapy 5, though this represents a higher dose than standard ACR recommendations.

Severe COVID-19 (Non-MIS-C)

For infants with severe acute COVID-19 pneumonia requiring oxygen support, dexamethasone is preferred over prednisolone, but if using prednisolone, the equivalent dose would be approximately 1-2 mg/kg/day for up to 10 days without need for taper given the shorter duration 6. This differs from MIS-C where longer courses with taper are required due to the distinct immunopathology.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.